← Back to Clinical Trials
Recruiting NCT07606573

NCT07606573 The SEAS Study: Sensory Engagement and Activation During Noninvasive Stimulation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07606573
Status Recruiting
Phase
Sponsor University of Minnesota
Condition Healthy Adult Participants
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-06-08
Primary Completion 2027-07

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
External electrical stimulationUltrasound stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2026-06-08 with a primary completion date of 2027-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Early feasibility study to establish quantitative physiological markers correlated with noninvasive stimulation.

Eligibility Criteria

Inclusion Criteria: * Able to provide written informed consent in English. * Willing and able to complete study procedures (e.g., \~1-hour sessions with non-invasive recordings, \~3-hour visit). Exclusion Criteria: * History of neurological disorders (e.g., epilepsy, migraines) or psychiatric conditions requiring medication. * Active implanted medical devices (e.g., pacemakers, cochlear implants) or metal in the neck/forearm that could interfere with stimulation or recordings. * Skin conditions or open wounds at stimulation sites (cervical neck, forearm). * Women who are pregnant or breastfeeding. * Current use of medications affecting autonomic or cortical function (e.g., beta-blockers, sedatives). * Inability to sit still for recordings or understand instructions (e.g., due to severe vision/hearing impairment).

Contact & Investigator

Central Contact

Rosana Esteller, Principal Investigator, PhD

✉ tntlab-studies@umn.edu

📞 612-624-1326

Frequently Asked Questions

Who can join the NCT07606573 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Healthy Adult Participants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07606573 currently recruiting?

Yes, NCT07606573 is actively recruiting participants. Contact the research team at tntlab-studies@umn.edu for enrollment information.

Where is the NCT07606573 trial being conducted?

This trial is being conducted at Minneapolis, United States, Minneapolis, United States, Minneapolis, United States.

Who is sponsoring the NCT07606573 clinical trial?

NCT07606573 is sponsored by University of Minnesota. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology